» Articles » PMID: 21829596

Copy Number Variation in Familial Parkinson Disease

Abstract

Copy number variants (CNVs) are known to cause Mendelian forms of Parkinson disease (PD), most notably in SNCA and PARK2. PARK2 has a recessive mode of inheritance; however, recent evidence demonstrates that a single CNV in PARK2 (but not a single missense mutation) may increase risk for PD. We recently performed a genome-wide association study for PD that excluded individuals known to have either a LRRK2 mutation or two PARK2 mutations. Data from the Illumina370Duo arrays were re-clustered using only white individuals with high quality intensity data, and CNV calls were made using two algorithms, PennCNV and QuantiSNP. After quality assessment, the final sample included 816 cases and 856 controls. Results varied between the two CNV calling algorithms for many regions, including the PARK2 locus (genome-wide p = 0.04 for PennCNV and p = 0.13 for QuantiSNP). However, there was consistent evidence with both algorithms for two novel genes, USP32 and DOCK5 (empirical, genome-wide p-values<0.001). PARK2 CNVs tended to be larger, and all instances that were molecularly tested were validated. In contrast, the CNVs in both novel loci were smaller and failed to replicate using real-time PCR, MLPA, and gel electrophoresis. The DOCK5 variation is more akin to a VNTR than a typical CNV and the association is likely caused by artifact due to DNA source. DNA for all the cases was derived from whole blood, while the DNA for all controls was derived from lymphoblast cell lines. The USP32 locus contains many SNPs with low minor allele frequency leading to a loss of heterozygosity that may have been spuriously interpreted by the CNV calling algorithms as support for a deletion. Thus, only the CNVs within the PARK2 locus could be molecularly validated and associated with PD susceptibility.

Citing Articles

Optical genome mapping of structural variants in Parkinson's disease-related induced pluripotent stem cells.

Trinh J, Schaake S, Gabbert C, Luth T, Cowley S, Fienemann A BMC Genomics. 2024; 25(1):980.

PMID: 39425080 PMC: 11490025. DOI: 10.1186/s12864-024-10902-1.


Genome-wide association study of copy number variations in Parkinson's disease.

Landoulsi Z, Ashok Kumar Sreelatha A, Schulte C, Bobbili D, Montanucci L, Leu C medRxiv. 2024; .

PMID: 39228715 PMC: 11370542. DOI: 10.1101/2024.08.21.24311915.


USP32 facilitates non-small cell lung cancer progression via deubiquitinating BAG3 and activating RAF-MEK-ERK signaling pathway.

Li S, Yang L, Ding X, Sun H, Dong X, Yang F Oncogenesis. 2024; 13(1):27.

PMID: 39030175 PMC: 11271578. DOI: 10.1038/s41389-024-00528-z.


Genetic landscape of Parkinson's disease and related diseases in Luxembourg.

Landoulsi Z, Pachchek S, Bobbili D, Pavelka L, May P, Kruger R Front Aging Neurosci. 2024; 15:1282174.

PMID: 38173558 PMC: 10761438. DOI: 10.3389/fnagi.2023.1282174.


USP32 deubiquitinase: cellular functions, regulatory mechanisms, and potential as a cancer therapy target.

Li S, Song Y, Wang K, Liu G, Dong X, Yang F Cell Death Discov. 2023; 9(1):338.

PMID: 37679322 PMC: 10485055. DOI: 10.1038/s41420-023-01629-1.


References
1.
Stefansson H, Ophoff R, Steinberg S, Andreassen O, Cichon S, Rujescu D . Common variants conferring risk of schizophrenia. Nature. 2009; 460(7256):744-7. PMC: 3077530. DOI: 10.1038/nature08186. View

2.
Sun M, Latourelle J, Wooten G, Lew M, Klein C, Shill H . Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Arch Neurol. 2006; 63(6):826-32. DOI: 10.1001/archneur.63.6.826. View

3.
Gibb W, Lees A . The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988; 51(6):745-52. PMC: 1033142. DOI: 10.1136/jnnp.51.6.745. View

4.
Simon-Sanchez J, Scholz S, Matarin M, Fung H, Hernandez D, Gibbs J . Genomewide SNP assay reveals mutations underlying Parkinson disease. Hum Mutat. 2007; 29(2):315-22. DOI: 10.1002/humu.20626. View

5.
Feuk L, Carson A, Scherer S . Structural variation in the human genome. Nat Rev Genet. 2006; 7(2):85-97. DOI: 10.1038/nrg1767. View